[ TRANSACTION RECORD ]

Novo Holdings A/S Investment in Catalent — 2024

VERIFIED VECTOR ID: 001537 · tx-065
M SOURCE NODE — FUNDER
Novo Holdings A/S
Healthcare Denmark
$16,500,000,000
EQUITY
05/02/2024
Q DESTINATION NODE — RECIPIENT
Catalent
Company United States
Amount (USD)
$16.5B
Flow Type
EQUITY
Transaction Date
05/02/2024
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Novo Holdings A/S
AUM 115000
HQ Location Denmark
Sector Healthcare
Recipient Profile [ Q ]
Entity Catalent
Entity Type Company
Jurisdiction United States
Intelligence Note

Novo Holdings A/S agreed to acquire Catalent for 16.5 billion dollars to expand its manufacturing capacity for life-saving medicines, including obesity treatments. The transaction involves taking the global contract development and manufacturing organization private. This deal is a strategic move to secure the supply chain for some of the world’s most in-demand pharmaceuticals.

Σ
Primary Forensic Source https://www.novoholdings.dk/news/novo-holdings-to-acquire-catalent/
✓ SOURCE LINKED